Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
Open Access
- 6 May 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet Digital Health
- Vol. 1 (1), e17-e25
- https://doi.org/10.1016/s2589-7500(19)30003-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDiabetes Care, 2016
- Toward Development of Psychosocial Measures for Automated Insulin DeliveryJournal of Diabetes Science and Technology, 2015
- 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trialThe Lancet Diabetes & Endocrinology, 2015
- Home Use of an Artificial Beta Cell in Type 1 DiabetesThe New England Journal of Medicine, 2015
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic RegistryDiabetes Care, 2015
- MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover TrialDiabetes Care, 2014
- Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic StudyDiabetes Technology & Therapeutics, 2014
- A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 YearsDiabetes Care, 2012
- The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic PatientsDiabetes Care, 2011
- Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of HypoglycemiaDiabetes Care, 1994